Is the Pharmaceutical Industry Missing Out on FMEA?
My June 2025 article, “How to Avoid FDA Warning Letters,” points out that inadequate corrective and preventive action (CAPA) is a major reason
My June 2025 article, “How to Avoid FDA Warning Letters,” points out that inadequate corrective and preventive action (CAPA) is a major reason
We’d be willing to bet your key collaborators aren’t all in the same building. Your team members, contract partners, clients, and suppliers are likely scattered across the globe.
When businesses talk about customer experience, the conversation almost always focuses on the end user. That’s understandable, but dangerously narrow.
A recent company meeting revealed what management called a “handoff problem.” The sales team would close deals, then toss them over the wall to the service team, which would promptly fumble the relationship because they didn’t understand what had been promised or why
Your market is shifting, your competitor just pulled ahead, and the one person who could execute the next move has resigned. You can’t get more data fast enough, yet the window to act is closing.
Small to midsize manufacturers are facing mounting pressure from unpredictable supply chain disruptions.
Software selection, implementation, and ongoing maintenance are critical stages in the life cycle of biomedical software systems such as asset and calibration management platforms.
Nano Tools for Leaders, a collaboration betwe
At Ramirez & Co., a midsize business with decades of wins, leadership thought its biggest challenges were competitors, technology, and the market. Close, but no cigar.
What if your quality system could detect and initiate corrective actions for equipment deviations before they affect product quality?
© 2026 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.